Pitfalls and solutions in assaying anandamide transport in cells

Journal of Lipid Research

Volumn 51, Issue 8, 2010, Pages 2435-2444

  Oddi, Sergio ^a,b   Fezza, Filomena ^b,c   Catanzaro, Giuseppina ^a,b   De Simone, Chiara ^a,c   Pucci, Mariangela ^a   Piomelli, Daniele ^d   Finazzi Agrò, Alessandro ^c   Maccarrone, Mauro ^a,b  

^a UNIVERSITY OF TERAMO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biotinylated derivative of anandamide; Confocal microscopy; Endocannabinoids; Glass coverslips; Lipid efflux; Plasticware

Indexed keywords

ANANDAMIDE; GLASS; PLASTIC; AMIDE; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; SILICATE;

ACCURACY; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KERATINOCYTE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TRANSPORT KINETICS; ADSORPTION; ARTIFACT; CELL PROLIFERATION; CHEMICAL PHENOMENA; CHEMISTRY; METABOLISM; SPECTROFLUOROMETRY; SURFACE PROPERTY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ADSORPTION; ARACHIDONIC ACIDS; ARTIFACTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL PROLIFERATION; GLASS; HUMANS; HYDROPHOBICITY; PLASTICS; POLYUNSATURATED ALKAMIDES; SILICATES; SPECTROMETRY, FLUORESCENCE; SURFACE PROPERTIES; ENDOCANNABINOIDS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS;

EID: 77956830425     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D004176     Document Type: Article

References (51)

1. Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258: 1946-1949.
2. Van der Stelt, M., and V. Di Marzo. 2005. Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat. 77: 111-122.
3. Starowicz, K., S. Nigam, and V. Di Marzo. 2007. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 114: 13-33.
4. Barann, M., G. Molderings, M. Bruss, H. Bonisch, B. W. Urban, and M. Gothert. 2002. Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br. J. Pharmacol. 137: 589-596.
5. Sawzdargo, M., T. Nguyen, D. K. Lee, K. R. Lynch, R. Cheng, H. H. Heng, S. R. George, and B. F. O'Dowd. 1999. Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res. Mol. Brain Res. 64: 193-198.
6. Lauckner, J. E., J. B. Jensen, H. Y. Chen, H. C. Lu, B. Hille, and K. Mackie. 2008. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc. Natl. Acad. Sci. USA. 105: 2699-2704.
7. Sun, Y., S. P. Alexander, D. A. Kendall, and A. J. Bennett. 2006. Cannabinoids and PPARalpha signalling. Biochem. Soc. Trans. 34: 1095-1097.
8. Sun, Y., and A. Bennett. 2007. Cannabinoids: a new group of agonists of PPARs. PPAR Res. 2007: 23513. (Pubitemid 350243193)
9. Bouaboula, M., S. Hilairet, J. Marchand, L. Fajas, G. Le Fur, and P. Casellas. 2005. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur. J. Pharmacol. 517: 174-181.
10. Gasperi, V., F. Fezza, N. Pasquariello, M. Bari, S. Oddi, A. Finazzi-Agrò, and M. Maccarrone. 2007. Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cell. Mol. Life Sci. 64: 219-229.
11. Rockwell, C. E., and N. E. Kaminski. 2004. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. J. Pharmacol. Exp. Ther. 311: 683-690.
12. Cravatt, B. F., K. Demarest, M. P. Patricelli, M. H. Bracey, D. K. Giang, B. R. Martin, and A. H. Lichtman. 2001. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA. 98: 9371-9376.
13. Piomelli, D. 2003. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4: 873-884.
14. Felder, C. C., A. K. Dickason-Chesterfield, and S. A. Moore. 2006. Cannabinoids biology: the search for new therapeutic targets. Mol. Interv. 6: 149-161.
15. McFarland, M. J., and E. L. Barker. 2004. Anandamide transport. Pharmacol. Ther. 104: 117-135.
16. Dainese, E., S. Oddi, M. Bari, and M. Maccarrone. 2007. Modulation of the endocannabinoid system by lipid rafts. Curr. Med. Chem. 14: 2702-2715.
17. Fowler, C. J., S. Holt, O. Nilsson, K. O. Jonsson, G. Tiger, and S. O. Jacobsson. 2005. The endocannabinoid signaling system: pharmacological and therapeutic aspects. Pharmacol. Biochem. Behav. 81: 248-262.
18. Grotenhermen, F. 2004. Pharmacology of cannabinoids. Neuroendocrinol. Lett. 25: 14-23.
19. Di Marzo, V. 2008. Targeting the endocannabinoid system: to enhance or reduce? Nat. Rev. Drug Discov. 7: 438-455.
20. Centonze, D., A. Finazzi-Agrò, G. Bernardi, and M. Maccarrone. 2007. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol. Sci. 28: 180-187.
21. Maccarrone, M., N. Battista, and D. Centonze. 2007. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Prog. Neurobiol. 81: 349-379.
22. Yates, M. L., and E. L. Barker. 2009. Organized trafficking of anandamide and related lipids. Vitam. Horm. 81: 25-53.
23. Fasia, L., V. Karava, and A. Siafaka-Kapadai. 2003. Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? Eur. J. Biochem. 270: 3498-3506.
24. Ortega-Gutierrez, S., E. G. Hawkins, A. Viso, M. L. Lopez-Rodriguez, and B. F. Cravatt. 2004. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Biochemistry. 43: 8184-8190.
25. Hillard, C. J., W. S. Edgemond, A. Jarrahian, and W. B. Campbell. 1997. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 69: 631-638.
26. Moore, S. A., G. G. Nomikos, A. K. Dickason-Chesterfield, D. A. Schober, J. M. Schaus, B. P. Ying, Y. C. Xu, L. Phebus, R. M. Simmons, D. Li, et al. 2005. Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc. Natl. Acad. Sci. USA. 102: 17852-17857.
27. Fegley, D., S. Kathuria, R. Mercier, C. Li, A. Goutopoulos, A. Makriyannis, and D. Piomelli. 2004. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc. Natl. Acad. Sci. USA. 101: 8756-8761.
28. Oddi, S., F. Fezza, N. Pasquariello, C. De Simone, C. Rapino, E. Dainese, A. Finazzi-Agrò, and M. Maccarrone. 2008. Evidence for the intracellular accumulation of anandamide in adiposomes. Cell. Mol. Life Sci. 65: 840-850.
29. McFarland, M. J., A. C. Porter, F. R. Rakhshan, D. S. Rawat, R. A. Gibbs, and E. L. Barker. 2004. A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. J. Biol. Chem. 279: 41991-41997.
30. Bari, M., N. Battista, F. Fezza, A. Finazzi-Agrò, and M. Maccarrone. 2005. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J. Biol. Chem. 280: 12212-12220.
31. Deutsch, D. G., S. T. Glaser, J. M. Howell, J. S. Kunz, R. A. Puffenbarger, C. J. Hillard, and N. Abumrad. 2001. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J. Biol. Chem. 276: 6967-6973.
32. Glaser, S. T., N. A. Abumrad, F. Fatade, M. Kaczocha, K. M. Studholme, and D. G. Deutsch. 2003. Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. USA. 100: 4269-4274.
33. Kaczocha, M., A. Hermann, S. T. Glaser, I. N. Bojesen, and D. G. Deutsch. 2006. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. J. Biol. Chem. 281: 9066-9075.
34. Fowler, C. J., G. Tiger, A. Ligresti, M. L. Lopez-Rodriguez, and V. Di Marzo. 2004. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis-a difficult issue to handle. Eur. J. Pharmacol. 492: 1-11.
35. Karlsson, M., C. Pahlsson, and C. J. Fowler. 2004. Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments. Eur. J. Pharm. Sci. 22: 181-189.
36. Di Marzo, V., A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J. C. Schwartz, and D. Piomelli. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372: 686-691.
37. Ligresti, A., E. Morera, M. Van Der Stelt, K. Monory, B. Lutz, G. Ortar, and V. Di Marzo. 2004. Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem. J. 380: 265-272.
38. Palmgren, J. J., J. Monkkonen, T. Korjamo, A. Hassinen, and S. Auriola. 2006. Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. Eur. J. Pharm. Biopharm. 64: 369-378.
39. Fezza, F., S. Oddi, M. Di Tommaso, C. De Simone, C. Rapino, N. Pasquariello, E. Dainese, A. Finazzi-Agrò, and M. Maccarrone. 2008. Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation. J. Lipid Res. 49: 1216-1223.
40. Oddi, S., M. Bari, N. Battista, D. Barsacchi, I. Cozzani, and M. Maccarrone. 2005. Confocal microscopy and biochemical analysis reveal spatial and functional separation between anandamide uptake and hydrolysis in human keratinocytes. Cell. Mol. Life Sci. 62: 386-395.
41. Thors, L., and C. J. Fowler. 2006. Is there a temperature-dependent uptake of anandamide into cells? Br. J. Pharmacol. 149: 73-81.
42. Maccarrone, M., M. Di Rienzo, N. Battista, V. Gasperi, P. Guerrieri, A. Rossi, and A. Finazzi-Agrò. 2003. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J. Biol. Chem. 278: 33896-33903.
43. Glaser, S. T., M. Kaczocha, and D. G. Deutsch. 2005. Anandamide transport: a critical review. Life Sci. 77: 1584-1604.
44. Battista, N., V. Gasperi, F. Fezza, and M. Maccarrone. 2005. The anandamide membrane transporter and the therapeutic implications of its inhibition. Therapy. 2: 141-150. (Pubitemid 40207821)
45. Rakhshan, F., T. A. Day, R. D. Blakely, and E. L. Barker. 2000. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J. Pharmacol. Exp. Ther. 292: 960-967.
46. Fowler, C. J. 2004. Possible involvement of the endocannabinoid system in the actions of three clinically used drugs. Trends Pharmacol. Sci. 25: 59-61.
47. Jonsson, K. O., S. Vandevoorde, D. M. Lambert, G. Tiger, and C. J. Fowler. 2001. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br. J. Pharmacol. 133: 1263-1275.
48. Maccarrone, M., M. Bari, N. Battista, and A. Finazzi-Agrò. 2002. Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood. 100: 4040-4048. (Pubitemid 35396871)
49. Kaczocha, M., S. T. Glaser, and D. G. Deutsch. 2009. Identification of intracellular carriers for the endocannabinoid anandamide. Proc. Natl. Acad. Sci. USA. 106: 6375-6380.
50. Oddi, S., F. Fezza, N. Pasquariello, A. D'Agostino, G. Catanzaro, C. De Simone, C. Rapino, A. Finazzi-Agrò, and M. Maccarrone. 2009. Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chem. Biol. 16: 624-632.
51. Ligresti, A., L. De Petrocellis, D. Hernan Perez de la Ossa, R. Aberturas, L. Cristino, A. S. Moriello, A. Finizio, M. E. Gil, A. I. Torres, J. Molpeceres, et al. 2010. Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter. PLoS ONE. 5: e10239.